查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611389

短读定序市场：按技术、产品、工作流程、应用程式和最终用户划分 - 2025-2030 年全球预测

Short-read Sequencing Market by Technology (Next-Generation Sequencing, Sanger Sequencing), Product (Consumables, Instruments, Services), Workflow, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

短读定序市场2023年估值为58.1亿美元，预计2024年将达到67.3亿美元，复合年增长率为15.98%，2030年将达到164.1亿美元。

短读长定序是一种用于对短 DNA 片段进行定序的高通量技术，在基因组学研究、个人化医疗和生物技术中至关重要。它对于全基因组关联研究、单细胞定序和诊断测试至关重要，并因其经济性、效率和准确性而受到重视。主要应用包括遗传疾病诊断、癌症基因组学和农业生物技术，主要最终用户为研究机构、诊断实验室和製药公司。由于技术进步、定序成本降低以及个人化医疗需求的增加，该市场正在蓬勃发展。与生物资讯学和人工智慧的整合进行资料分析增加了其效用。然而，短读长无法处理重复区域或复杂的基因组组装，因此在没有长读长技术支援的情况下，它们存在准确性和解释问题等限制。有关基因组资料隐私的道德问题和监管复杂性也对市场成长构成挑战。透过结合短读和长读的混合方法以及改进资料解释演算法，有很多机会可以提高定序准确性。创新还可以集中于开发可携式定序设备、扩展云端基础的基因组资料解决方案，以及将定序整合到各种医疗保健应用的照护现场诊断中。该市场的特点是快速创新、竞争激烈和多体学方法的整合。公司应投资研发，以改善技术、解决资料隐私问题，并倡导相关人员持续参与，以有效应对监管环境。此外，与人工智慧和生物资讯公司的策略伙伴关係可以在资料处理能力、个人化医疗创新和拓展开拓市场方面提供优势。随着该领域的发展，相关人员必须专注于透过增强的定序解决方案创造价值，以解决当前的限制和新兴的医疗保健需求。

主要市场统计
基准年[2023] 58.1亿美元
预计年份 [2024] 67.3亿美元
预测年份 [2030] 164.1亿美元
复合年增长率（%） 15.98%

市场动态：揭示快速发展的短读定序市场的关键市场洞察

供需的动态交互作用正在改变短读定序市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对个人化医疗和伴同性诊断的需求不断增长
    • 临床研究未知基因突变检测的低成本定序需求增加
    • 肿瘤学、感染疾病、生殖筛检和药物基因组学等应用领域的需求快速成长
  • 市场限制因素
    • 缺乏熟练的专业人员，高成本
  • 市场机会
    • 持续开发降低基因组定序成本
    • 加强基因序列测定合作
  • 市场挑战
    • 新兴国家缺乏必要的基础设施

波特五力：驾驭短读定序市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解短读定序市场的外部影响

外部宏观环境因素在塑造短读定序市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解短读长定序市场的竞争格局

对短读定定序市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵短读定序市场供应商绩效评估

FPNV定位矩阵是评估短读长定序市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了短读定序市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，短读定定序市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对个人化医疗和伴同性诊断的需求不断增长
      • 由于临床研究中用于检测未知基因突变的低成本定序的需求不断增加
      • 肿瘤学、感染疾病、生殖筛检和药物基因组学等应用领域的需求快速成长
    • 抑制因素
      • 缺乏熟练的专业人员，高成本
    • 机会
      • 持续开发降低基因组定序成本
      • 扩大基因序列分析合作
    • 任务
      • 新兴国家缺乏必要的基础设施
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章短读定定序市场：依技术分类

  • 次世代定序
  • 桑格序列

第 7 章短读定定序市场：副产品

  • 消耗品
  • 装置
  • 服务

第 8 章短读定定序市场：依工作流程

  • 资料分析
  • 前序
  • 定序

第九章短读定定序市场：依应用分类

  • 农业基因组学与法医学
  • 临床调查
  • 消费者基因体学
  • HLA型检测和免疫系统监测
  • 总体基因体学、流行病学、药物开发
  • 肿瘤学
  • 生殖健康

第 10 章 短读定定序市场：依最终使用者分类

  • 学术研究
  • 临床调查
  • 医院/诊所
  • 製药和生物技术公司

第十一章美洲短读定序市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太短读定序市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲短读定序市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Almac Group
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Eurofins Genomics LLC
  • F. Hoffmann La Roche AG
  • General Electric Company
  • Genexa AG
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Seven Bridges Genomics, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD898498

The Short-read Sequencing Market was valued at USD 5.81 billion in 2023, expected to reach USD 6.73 billion in 2024, and is projected to grow at a CAGR of 15.98%, to USD 16.41 billion by 2030.

Short-read sequencing is a high-throughput technology used to determine the sequence of short DNA fragments, pivotal in genomics research, personalized medicine, and biotechnology. It is indispensable for genome-wide association studies, single-cell sequencing, and diagnostic testing due to its affordability, efficiency, and accuracy. Key applications include genetic disorder diagnostics, cancer genomics, and agricultural biotechnology with major end-users being research institutions, diagnostic labs, and pharmaceutical companies. The market is buoyed by technological advancements, decreasing sequencing costs, and increasing demand for personalized medicine. Integration with bioinformatics and AI for data analysis enhances its utility. However, limitations include short reads' inability to span repetitive regions and complex genome assemblies, leading to challenges in accuracy and interpretation without the support of long-read technologies. The market growth is also challenged by ethical issues concerning genomic data privacy and regulatory complexities. Numerous opportunities lie in enhancing sequencing accuracy through hybrid approaches combining short and long reads or improving algorithms for data interpretation. Innovation can also focus on developing portable sequencing devices, expanding cloud-based genomic data solutions, and integrating sequencing into point-of-care diagnostics for broader healthcare applications. The market is characterized by rapid innovation, competitive collaboration, and integration of multi-omics approaches. Companies should invest in R&D to refine technologies, address data privacy concerns, and advocate for continuous stakeholder engagement to navigate regulatory landscapes effectively. Strategic partnerships with AI and bioinformatics firms can also provide an edge in data handling capabilities, personalized medicine innovations, and expansion into untapped markets. As the field evolves, stakeholders must focus on creating value through enhanced sequencing solutions that address both current limitations and emerging healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 5.81 billion
Estimated Year [2024] USD 6.73 billion
Forecast Year [2030] USD 16.41 billion
CAGR (%) 15.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Short-read Sequencing Market

The Short-read Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for personalized medicine and companion diagnostics
    • Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
    • Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
  • Market Restraints
    • Shortage of skilled professionals and high cost
  • Market Opportunities
    • Ongoing developments to decrease the cost of genome sequencing
    • Growing collaboration for genetic sequencing
  • Market Challenges
    • Dearth of required infrastructure in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Short-read Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Short-read Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Short-read Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Short-read Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Short-read Sequencing Market

A detailed market share analysis in the Short-read Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Short-read Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Short-read Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Short-read Sequencing Market

A strategic analysis of the Short-read Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Short-read Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Almac Group, Azenta Life Sciences, BGI Genomics Co., Ltd., Eurofins Genomics LLC, F. Hoffmann La Roche AG, General Electric Company, Genexa AG, GenScript Biotech Corporation, Illumina, Inc., PerkinElmer, Inc., Qiagen N.V., Seven Bridges Genomics, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Short-read Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Next-Generation Sequencing and Sanger Sequencing.
  • Based on Product, market is studied across Consumables, Instruments, and Services.
  • Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
  • Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing & Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
  • Based on End-User, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for personalized medicine and companion diagnostics
      • 5.1.1.2. Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
      • 5.1.1.3. Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of skilled professionals and high cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing developments to decrease the cost of genome sequencing
      • 5.1.3.2. Growing collaboration for genetic sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of required infrastructure in emerging economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Short-read Sequencing Market, by Technology

  • 6.1. Introduction
  • 6.2. Next-Generation Sequencing
  • 6.3. Sanger Sequencing

7. Short-read Sequencing Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Instruments
  • 7.4. Services

8. Short-read Sequencing Market, by Workflow

  • 8.1. Introduction
  • 8.2. Data Analysis
  • 8.3. Pre-Sequencing
  • 8.4. Sequencing

9. Short-read Sequencing Market, by Application

  • 9.1. Introduction
  • 9.2. Agrigenomics & Forensics
  • 9.3. Clinical Investigation
  • 9.4. Consumer Genomics
  • 9.5. HLA Typing & Immune System Monitoring
  • 9.6. Metagenomics, Epidemiology & Drug Development
  • 9.7. Oncology
  • 9.8. Reproductive Health

10. Short-read Sequencing Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Research
  • 10.3. Clinical Research
  • 10.4. Hospitals & Clinics
  • 10.5. Pharma & Biotech Entities

11. Americas Short-read Sequencing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Short-read Sequencing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Short-read Sequencing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Almac Group
  • 4. Azenta Life Sciences
  • 5. BGI Genomics Co., Ltd.
  • 6. Eurofins Genomics LLC
  • 7. F. Hoffmann La Roche AG
  • 8. General Electric Company
  • 9. Genexa AG
  • 10. GenScript Biotech Corporation
  • 11. Illumina, Inc.
  • 12. PerkinElmer, Inc.
  • 13. Qiagen N.V.
  • 14. Seven Bridges Genomics, Inc.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. SHORT-READ SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. SHORT-READ SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SHORT-READ SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SHORT-READ SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HLA TYPING & IMMUNE SYSTEM MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023